KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Steris (STE) Capital Expenditures (2018 - 2025)

Steris (STE) has 8 years of Capital Expenditures data on record, last reported at $98.7 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 10.65% year-over-year to $98.7 million; the TTM value through Dec 2025 reached $349.7 million, down 10.5%, while the annual FY2025 figure was $370.1 million, 2.71% up from the prior year.
  • Capital Expenditures reached $98.7 million in Q4 2025 per STE's latest filing, up from $86.5 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $118.9 million in Q4 2023 and bottomed at $56.4 million in Q2 2021.
  • Average Capital Expenditures over 5 years is $86.7 million, with a median of $84.9 million recorded in 2023.
  • Peak YoY movement for Capital Expenditures: soared 105.57% in 2022, then tumbled 42.55% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $81.1 million in 2021, then increased by 13.19% to $91.8 million in 2022, then rose by 29.53% to $118.9 million in 2023, then fell by 25.0% to $89.2 million in 2024, then rose by 10.65% to $98.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $98.7 million in Q4 2025, $86.5 million in Q3 2025, and $93.6 million in Q2 2025.